Sandeep Jain ,
Founder & MD,
Akums Drugs & Pharmaceuticals Limited,
In today’s pharmaceutical industry, technology is more than just a tool - it is a strategic necessity. As regulatory expectations increase, market demands grow more complex, and global competition intensifies, pharmaceutical manufacturing is increasingly turning to technology to drive operational efficiency, scalability, ensure quality, and precision.Akums Drugs & Pharmaceuticals Limited recognizes this critical imperative and has embraced advanced technologies to drive operational excellence, maintain superior quality standards, and promote continuous innovation. Positioned at the forefront of this industry transformation, Akums has seamlessly integrated technology into its core operations, enabling the company to evolve into a future-ready leader dedicated to shaping the future of pharmaceutical manufacturing.
By leveraging state-of-the-art automation, digitalization, and data-driven decision-making, Akums consistently achieves higher productivity levels while adhering to the most rigorous quality standards. The company’s commitment to innovation is reflected in its continuous investment in research and development, advanced manufacturing technologies, and quality assurance systems. This holistic approach not only ensures the delivery of safe, effective, and high-quality pharmaceutical products but also positions Akums as a resilient and agile organization ready to meet future industry challenges.
Redefining Possibilities in Pharma
The future of pharmaceutical manufacturing lies at the intersection of advanced science, modern technology, and continuous innovation. Akums has integrated advanced technology into every aspect of its operations, redefining possibilities in pharmaceutical manufacturing and development.0=
In FY 2024-25, Akums achieved a consolidated turnover of INR 4,170 crores, reinforcing its position as a leading player in the industry. The company’s extensive portfolio includes 973 DCGI approvals and over 4,000 commercialized formulations across more than 60 dosage forms. With a strong emphasis on research and development, Akums invested INR 130 crore in FY25 - over 3% of its revenue - highlighting its commitment to innovation.
Akums’ strength is further supported by 12 world-class manufacturing facilities and 4 state-of-the-art R&D centers staffed by over 400 scientists who focus on developing novel drug delivery systems and improving existing formulations. This technological and scientific prowess enables the company to meet evolving industry demands while delivering innovative solutions that improve healthcare outcomes globally.
As a leading pharmaceutical Contract Development and Manufacturing Organization (CDMO) in India, Akums has made significant investments in advanced manufacturing technologies, automation, and data integrity tools. Its success is driven by technology-enabled processes, a skilled workforce, visionary leadership, and collaborative partnerships - all aligned with a shared vision of making healthcare more accessible and transformative.
Built on Values, Driven by Technology
Founded in 2004 by brothers Sanjeev Jain and Sandeep Jain, Akums grew from a shared vision to serve the nation through enterprise. Coming from a humble middle-class background, the Jain brothers were inspired by the values instilled by their late father, Shri D.C. Jain, whose dedication and resilience shaped their business philosophy. What began as a small pharmaceutical trading store in Chandni Chowk, Old Delhi in 1984 has evolved into India’s largest Contract Development and Manufacturing Organization (CDMO) - a transformation powered not just by vision, but by early and bold investments in advanced technologies.
As Founders and Managing Directors, Sanjeev and Sandeep Jain have been instrumental in driving Akums strategic growth and transformation. Their leadership goes beyond business development, focusing equally on talent, innovation, operational excellence, and ethical integrity. Sanjeev Jain leads Akums business expansion and global strategy. Through strategic partnerships, international alliances, and market diversification, he has significantly scaled the company’s presence and reinforced its reputation as a reliable, quality-focused pharmaceutical partner. Sandeep Jain champions a people-centric leadership style that aligns employee empowerment with organizational performance. He emphasizes operational excellence and the consistent delivery of high-quality pharmaceutical products. His leadership has fostered a high-performance culture supported by streamlined processes, strong quality frameworks, and a workforce that is agile, skilled, and innovation-driven.
Akums is harnessing the power of technology across key functions - including customer relationship management, legal, procurement, planning, and data analysis - to drive productivity, enhance transparency, and enable data-driven decision-making at every level. This digital integration empowers teams and leaders alike to act with greater speed, clarity, and confidence. At the helm of this transformation are brothers Sanjeev Jain and Sandeep Jain, Founders and Managing Directors, whose strategic foresight has consistently placed technology at the core of Akums growth. Their leadership is defined not only by a clear vision but also by a passion for building future-ready teams and embedding innovation into every layer of the organization. The Jain brothers strongly believe that people and technology together drive lasting success. Under their guidance, Akums has cultivated a culture where tech-driven decision-making, agile execution, and continuous improvement are woven into the company’s DNA. Today, Akums stands not just as a pharmaceutical leader, but as a beacon of how technology, purpose, and people can converge to build a healthier, more empowered future.
Focus on R&D and Innovation
At the forefront of pharmaceutical innovation, Akums has positioned research and development as a strategic cornerstone of its growth and value creation. Operating four state-of-the-art R&D centres, the company is backed by a team of over 400 highly qualified scientists, formulation experts, and technical professionals with deep expertise across a wide range of therapeutic segments. Akums R&D capabilities are focused on developing innovative, high-quality, and cost-effective formulations that address evolving patient needs and meet global market demands. This commitment to innovation has resulted in the successful launch of numerous first-in-market products in India, particularly in fast-growing segments such as dermatology, cosmeceuticals, nutraceuticals, and key pharmaceutical categories.
What sets Akums apart is not only its ability to innovate but also its proven excellence in technology transfer. The company has built robust, scalable systems that ensure smooth and efficient transitions from lab-scale development to full-scale commercial production - without compromising on quality, regulatory compliance, or timelines. Through an integrated approach that combines R&D, regulatory support, and advanced manufacturing, Akums accelerates time-to-market for its partners. This capability has made the company a trusted strategic partner for both Indian and global pharmaceutical players. Whether developing complex generics, novel drug delivery systems, or tailored formulations, Akums continues to lead with science, translating innovation into meaningful healthcare outcomes for patients worldwide.
Innovating Today for a Healthier Tomorrow
Akums Drugs & Pharmaceuticals stands as a leader in pharmaceutical innovation, with a portfolio comprising over 4,000 commercialized formulations and a strong pipeline of more than 200 innovative products across 60+ dosage forms. Its influence extends well beyond India, delivering advanced healthcare solutions to global markets - underscoring a deep-rooted commitment to scientific excellence and continuous innovation. This capability is supported by world-class manufacturing facilities and advanced R&D centers, all equipped with state-of-the-art technology and cutting-edge infrastructure. These centers serve as the backbone of Akums' agility in responding to the rapidly evolving needs of the pharmaceutical industry.
At the core of its innovation engine is a team of skilled scientists and researchers dedicated to the development of novel drug delivery systems, the optimization of existing formulations, and the exploration of new therapeutic frontiers. Their expertise ensures that Akums not only keeps pace with global industry trends but actively sets new standards in pharmaceutical development. By pushing the boundaries of traditional manufacturing and embracing next-generation scientific approaches, Akums continues to redefine possibilities in healthcare. Its innovations aim to improve patient outcomes, enhance treatment experiences, and expand access to advanced therapies—reinforcing the company’s position as a global frontrunner in pharmaceutical manufacturing and research.
Building a Future Ready Enterprise
In a sector where precision, product quality, and innovation are essential to maintaining a resilient healthcare ecosystem, Akums Drugs has firmly Akums leverages advanced digital platforms such as LIMS for real-time quality monitoring and Ample Logic for a robust, integrated Quality Management System. Its proprietary Single-Window System (SWS) streamlines both capital and operational expenditures, enabling faster, data-driven decision-making and improved organizational agility. In an era defined by scientific acceleration, evolving regulatory demands, and increasing patient needs, Akums demonstrates that technology is no longer optional - it's imperative.
Innovation at Akums extends far beyond the production floor. Biometric and facial recognition systems drive workforce efficiency, while a cloud-hosted data center provides secure, centralized access to critical business data. The company’s early adoption of SAP has ensured seamless cross-functional integration from the outset. Technology also drives Akums planning and packaging functions. Advanced digital tools support optimized production planning, while Harmony software enhances both precision and creativity in packaging design. By embedding intelligent technologies across every layer of its operations, Akums not only meets the highest global standards but cultivates a culture of agility, innovation, and continuous improvement - cementing its position as a future-ready leader in pharmaceutical manufacturing.
Digital Transformation and Sustainability
Akums Drugs & Pharmaceuticals Limited is spearheading a digital transformation that enhances productivity while strengthening its commitment to environmental sustainability. Through regular audits and ongoing improvements in energy-saving practices, along with the treatment of wastewater via Sewage Treatment Plants (STP) and Effluent Treatment Plants (ETP) across its manufacturing facilities, the company has achieved significant reductions in both energy and water consumption. Since its inception, Akums has aligned its operations with global Environmental, Social, and Governance (ESG) standards, embracing green initiatives such as native tree plantations, renewable energy adoption, energy-efficient infrastructure, and water recycling systems. These efforts underscore Akums’ dedication to sustainable and responsible growth.
Serving over 1,500 pharmaceutical companies across India and exporting to more than 60 countries - including highly regulated markets - Akums has established itself as a trusted partner for pharmaceutical giants. Its technology-led manufacturing excellence and stringent compliance protocols position the company as a preferred choice for those seeking reliable outsourcing solutions that meet international quality standards. As the Indian pharmaceutical sector becomes increasingly complex and globally relevant, Akums is more than just a manufacturing partner - it is a technological enabler of healthcare innovation. Through continued investment in cutting-edge technologies, research and development, and world-class quality systems, Akums has earned its place as a technology leader in the industry, consistently setting new benchmarks.
At its core, Akums represents more than pharmaceutical expertise - it embodies a legacy of technology, innovation, and continuous progress. Since its foundation, the company has remained committed to improving lives, generating employment opportunities, and making a meaningful contribution to the community beyond commercial success.
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
